1. Medtech Insight
  2. >>Business

Boston Scientific Q3 Beats Expectations, Emerging Markets Boost Biz

 
• By Catherine Longworth

Boston Scientific reported higher than expected Q3 results, with growth across emerging markets boosting company revenue. A number of product launches across the business also helped to drive growth.

Quarterly resluts on typewriter close up

Boston Scientific Corp. reported sales of $2.7bn during Q3 2019, a year-on-year increase of 13.1%, exceeding analyst expectations.

Growth was driven by strength across geographic and business divisions, including Interventional cardiology (14.6%), endoscopy (10.4%), urology and pelvic health...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

Ochsner Surgeon In ‘The Big Easy’ Eases Patient’s Pain With Skill And Virtual Reality

 
• By Brian Bossetta

A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.

Execs On The Move: June 30–July 4, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

FDA Commissioner’s Voucher Program Should Include Devices, Transplant Technology Firm Says

 
• By Elizabeth Orr

The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.